WCN25-1664 Epidemiology, disease burden and treatment patterns for primary IgA nephropathy patients: A real-world data study in The Netherlands
58%) were from the most deprived areas, and 57 (28%) were from middle-range areas.Conclusions: This study highlights significant gaps in lipid management among pre-dialysis CKD patients, with a notable disparity affecting those from socioeconomically deprived areas.Despite established guidelines, a considerable number of patients remain untreated or inadequately controlled for dyslipidemia, increasing their risk for cardiovascular events.These findings underscore the urgent need for targeted interventions and more equitable healthcare strategies to enhance lipid control, particularly in vulnerable populations.Regular monitoring and appropriate use of LLT are essential steps in reducing CVD risk and improving outcomes for CKD patients.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.
Authors
- Thom S. Lysen (ORCID: https://orcid.org/0000-0002-7593-935X)
- Alice Eberhardt
- Brenda N. Baak
- Hema K. Gandhi
- Sasikiran Nunna (ORCID: https://orcid.org/0000-0002-8006-7306)
- Raphaël Duivenvoorden (ORCID: https://orcid.org/0000-0003-1446-8336)
- Jetty A. Overbeek (ORCID: https://orcid.org/0000-0003-0935-5193)
- Naomi Reines
- Lisa Smitts
Institutions
- Radboud University Nijmegen (NL)
- Radboud University Medical Center (NL)
- Otsuka (United States) (US)
- Pharmo Institute (NL)
- Otsuka Pharmaceutical (Spain) (ES)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1016/j.ekir.2024.11.538
- Citations
- 1
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 1.43